Trial Profile
Iowa State Study on Flax Lignans and Heart Health.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Secoisolariciresinol diglucoside (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms ISULignan
- 18 Mar 2011 New trial record